Drozitumab (Anti-TNFRSF10B / TRAILR2 / CD262)
Drozitumab (Anti-TNFRSF10B / TRAILR2 / CD262) (A2758-GRP)
Products
Description
Drozitumab (Anti-TNFRSF10B / TRAILR2 / CD262) is a human monoclonal antibody targeted against the death receptor DR5 (TRAILR2, CD262, TNFRSF10B) with potent anti-tumor activity against rhabdomyosarcoma (RMS) xenografts. MW: 150 kD.
Specifications
| Manufacturer | Selleck Chemicals LLC |
|---|---|
| Manufacturer Cat# | A2758 |
| Target | CD markers |